Dyspepsia
📧 Sign up to get email alerts when something new happens for Dyspepsia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-02-29FDA Approved: ACID REDUCER — Original Application (WinCo Foods, LLC)
FDA approved an original application for a generic ranitidine hydrochloride product called ACID REDUCER by WinCo Foods, LLC.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patient With or Without Local Pharyngeal Anaesthesia [Phase 3]
A Phase 3 trial comparing ultrathin versus conventional esophagogastroduodenoscopy in unsedated patients (with or without local pharyngeal a…
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Montelukast in the Treatment of Duodenal Eosinophilia [NA]
Clinical trial update notes completion of a Montelukast trial for duodenal eosinophilia, investigated in children.
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia [Phase 3]
A Phase 3 trial assessed the efficacy and safety of Cinitapride tablets for mild-to-moderate functional dyspepsia and has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Supplementation With L. Reuteri in H. Pylori Infected Adults [NA]
A clinical trial update describing supplementation with Lactobacillus reuteri in adults infected with Helicobacter pylori to address dyspeps…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Defining Central Circuits of Pain [NA]
A Massachusetts General Hospital-sponsored clinical trial on defining central circuits of pain related to dyspepsia has completed.
-
CLINICAL_TRIALS research · 2011-06-22Clinical Trial Update: Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus Reuteri [NA]
A clinical trial exploring whether Lactobacillus reuteri dietary supplementation can control Helicobacter pylori infection and related dyspe…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Gastric Motor Function Measurement in Dyspepsia and Normal Subjects [NA]
This Mayo Clinic study completed its clinical evaluation of gastric motor function in individuals with dyspepsia and in healthy controls.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Nexium Dyspepsia/AST [Phase 3]
Nexium, esomeprazole, was studied in a Phase 3 trial for dyspepsia. The study status is completed according to the update.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Nexium Dyspepsia/AST [Phase 3]
Phase 3 trial update indicates the Nexium study for dyspepsia has completed.
-
FDA approval · 2010-10-29FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for famotidine from Dr. Reddy's Laboratories Limited, authorizing a modification to an existing …
-
FDA approval · 2010-10-27FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Pharmaceutical Associates, Inc. The approval updates the product's e…
-
FDA approval · 2010-07-15FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for famotidine from Alembic Pharmaceuticals Inc., adding approved changes to the product under the A…
-
FDA approval · 2010-05-27FDA Approved: FAMOTIDINE — Original Application (Navinta LLC)
FDA approves Navinta LLC's original application for famotidine. This approval permits a generic version of famotidine to enter the market.
-
FDA approval · 2010-04-30FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Proton Pump Inhibitor Treatment Stop [Phase 4]
A Phase 4 clinical trial evaluating stopping proton pump inhibitor therapy in dyspepsia has completed.
-
FDA approval · 2009-08-31FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ranitidine by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2009-06-16Clinical Trial Update: Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients [Phase 2]
Phase 2 study evaluating the efficacy and safety of finafloxacin in patients with Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS research · 2009-04-29Clinical Trial Update: Use of MRI for Assessing Stomach Relaxation in Response to a Meal [Phase 1]
Phase 1 clinical trial using MRI to assess stomach relaxation after a meal in participants with dyspepsia and healthy volunteers has complet…
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease [Phase 3]
Phase 3 HEARD long-term study evaluating histology of the esophagus in acid-related disease has completed, sponsored by AstraZeneca.
-
FDA approval · 2009-02-27FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.
-
FDA approval · 2008-11-24FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
FDA approved a supplemental application for ACID CONTROLLER (famotidine) from H E B. The approval expands the product's labeling/indications…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Evaluation of Food Hypersensitivity in Children/Adolescents With Functional Dyspepsia [Phase 1]
A Phase 1 clinical trial evaluating food hypersensitivity in children and adolescents with functional dyspepsia has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-05Clinical Trial Update: Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy [NA]
This completed clinical trial evaluated the effectiveness of esophageal capsule endoscopy for screening patients with gastroesophageal reflu…
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved Sagent Pharmaceuticals' supplemental application for famotidine under an existing ANDA, updating the product's approved lab…